
Frantz EyeCare reports 98% of Light Adjustable Lens patients achieved refractive accuracy within ±0.50 D of target, exceeding published national cataract surgery benchmarks.
Any T cell-mediated disease found to benefit from this therapy without affecting other inflammatory pathways




